Ad is loading...
MLMCX vs RPEBX
MLMCX vs RPEBX Comparison
Open Charts MLMCX vs RPEBX
Morgan Stanley Instl Global Core C
Price$20.62
Change-$0.30 (-1.43%)
VolumeN/A
Net Assets40.9M
American Funds New Perspective R2E
Price$63.11
Change-$0.77 (-1.21%)
VolumeN/A
Net Assets147.51B
MLMCX vs RPEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
MLMCX vs. RPEBX commentary
Feb 23, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLMCX is a Buy and RPEBX is a StrongBuy.
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 148B vs. MLMCX (40.9M). RPEBX pays higher dividends than MLMCX: RPEBX (0.46) vs MLMCX (0.00). MLMCX was incepted earlier than RPEBX: MLMCX (9 years) vs RPEBX (10 years). MLMCX is a more actively managed with annual turnover of: 18.00 vs. RPEBX (17.00). RPEBX has a lower initial minimum investment than MLMCX: RPEBX (250) vs MLMCX (1000). MLMCX annual gain was more profitable for investors over the last year : 16.76 vs. RPEBX (9.79). MLMCX return over 5 years is better than : 53.65 vs. RPEBX (31.20).
| MLMCX | RPEBX | MLMCX / RPEBX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 9 years | 10 years | - |
| Gain YTD | 4.511 | 4.539 | 99% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 40.9M | 148B | 0% |
| Annual Yield % from dividends | 0.00 | 0.46 | - |
| Returns for 1 year | 16.76 | 9.79 | 171% |
| Returns for 3 years | 31.84 | 13.14 | 242% |
| Returns for 5 years | 53.65 | 31.20 | 172% |
| Returns for 10 years | N/A | 67.02 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| KDHCX | 56.24 | -0.08 | -0.14% |
| DWS CROCI Equity Dividend C | |||
| GQGRX | 16.52 | -0.13 | -0.78% |
| GQG Partners Emerging Markets Equity R6 | |||
| TQMVX | 17.90 | -0.22 | -1.21% |
| T. Rowe Price Integrated US LCV Eq | |||
| NBGTX | 29.41 | -0.58 | -1.93% |
| Neuberger Berman Large Cap Growth Tr | |||
| FSCAX | 31.55 | -0.63 | -1.96% |
| Nuveen Small Cap Value A | |||